Keywords: roche, beats, forecasts, sales, up, swiss, major
Roche beats forecasts with sales up 19%
Article | 09 February 2004
Swiss major Roche saw double-digit gains in 2003, posting turnover of 29.0 billion Swiss francs ($22.97 billion), up 19% in local currencies and 11% in ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
